These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Network Pharmacology-Based and Molecular Docking Analysis of Resveratrol's Pharmacological Effects on Type I Endometrial Cancer. Zhong Z; Guo X; Zheng Y Anticancer Agents Med Chem; 2022; 22(10):1933-1944. PubMed ID: 34773964 [TBL] [Abstract][Full Text] [Related]
3. Potential Modulation of Human NAD[P]H-Quinone Oxidoreductase 1 (NQO1) by EGCG and Its Metabolites-A Systematic Computational Study. Pandey P; Avula B; Khan IA; Khan SI; Navarro VJ; Doerksen RJ; Chittiboyina AG Chem Res Toxicol; 2020 Nov; 33(11):2749-2764. PubMed ID: 32975120 [TBL] [Abstract][Full Text] [Related]
7. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity. Megarity CF; Timson DJ Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431515 [TBL] [Abstract][Full Text] [Related]
8. Alkynyloxy derivatives of 5,8-quinolinedione: Synthesis, in vitro cytotoxicity studies and computational molecular modeling with NAD(P)H:Quinone oxidoreductase 1. Kadela-Tomanek M; Jastrzębska M; Pawełczak B; Bębenek E; Chrobak E; Latocha M; Książek M; Kusz J; Boryczka S Eur J Med Chem; 2017 Jan; 126():969-982. PubMed ID: 28006669 [TBL] [Abstract][Full Text] [Related]
10. NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy. Qiu D; Song S; Wang Y; Bian Y; Wu M; Wu H; Shi Y; Duan H J Transl Med; 2022 Jan; 20(1):44. PubMed ID: 35090502 [TBL] [Abstract][Full Text] [Related]
11. Vaghefinezhad N; Farsani SF; Gharaghani S Curr Drug Discov Technol; 2021; 18(1):139-157. PubMed ID: 31721705 [TBL] [Abstract][Full Text] [Related]
12. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer. Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977 [TBL] [Abstract][Full Text] [Related]
13. Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies. Hassani M; Cai W; Koelsch KH; Holley DC; Rose AS; Olang F; Lineswala JP; Holloway WG; Gerdes JM; Behforouz M; Beall HD J Med Chem; 2008 Jun; 51(11):3104-15. PubMed ID: 18457384 [TBL] [Abstract][Full Text] [Related]
14. In-silico Design, ADMET Screening, Prime MM-GBSA Binding Free Energy Calculation and MD Simulation of Some Novel Phenothiazines as 5HT6R Antagonists Targeting Alzheimer's Disease. V P; A M; N R Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38204222 [TBL] [Abstract][Full Text] [Related]
15. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Hsieh TC; Lu X; Wang Z; Wu JM Med Chem; 2006 May; 2(3):275-85. PubMed ID: 16948474 [TBL] [Abstract][Full Text] [Related]
16. Akash S; Islam MR; Bhuiyan AA; Islam MN; Bayıl I; Saleem RM; Albadrani GM; Al-Ghadi MQ; Abdel-Daim MM Front Oncol; 2024; 14():1360745. PubMed ID: 38746675 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Li Y; Cao Z; Zhu H Pharmacol Res; 2006 Jan; 53(1):6-15. PubMed ID: 16169743 [TBL] [Abstract][Full Text] [Related]
18. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases. Martinek V; Kubickova B; Arlt VM; Frei E; Schmeiser HH; Hudecek J; Stiborova M Neuro Endocrinol Lett; 2011; 32 Suppl 1():57-70. PubMed ID: 22167209 [TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanism of Resveratrol's Lipid Membrane Protection. Fei Q; Kent D; Botello-Smith WM; Nur F; Nur S; Alsamarah A; Chatterjee P; Lambros M; Luo Y Sci Rep; 2018 Jan; 8(1):1587. PubMed ID: 29371621 [TBL] [Abstract][Full Text] [Related]
20. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations. Rezvani S; Ebadi A; Razzaghi-Asl N J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]